Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAART

AIDS Research and Human Retroviruses

Volumn 22, Issue 3, 2006, Pages 283-288

  Weinberg, Adriana ^a,e   Wiznia, Andrew A ^b   Lafleur, Bonnie J ^c   Shah, Sona ^d   Levin, Myron J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b JACOBI MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Indiancrest Pediatrics   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GAMMA INTERFERON; GANCICLOVIR;

ADOLESCENT; ADULT; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; INFANT; INTERFERON PRODUCTION; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; INFANT; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MALE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VIRUS REPLICATION;

EID: 33645365899     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.283     Document Type: Article

References (26)

1. Fauci AS, Schnittman SM, Poli G, Koenig S, and Pantaleo G: NIH conference: Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991; 114:678-693.
2. Palella FJ, Jr., Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
3. Erice A, Tierney C, Hirsch M, et al.: Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin Infect Dis 2003;37:567-578.
4. Weinberg A, Pahwa S, Oyomopito R, et al.: Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis 2004;39:107-114.
5. Connick E, Lederman MM, Kotzin BL, et al.: Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis 2000;181:357-363.
6. Havlir DV, Schrier RD, Torriani FJ, Chervenak K, Hwang JY, and Boom WH: Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects. J Infect Dis 2000;182:1658-1663.
7. + T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
8. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, and Autran B: Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998;351:1682-1686.
9. + T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis 2001;183: 1399-1404.
10. + cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis. J Infect Dis 2004;189:1362-1373.
11. Martinez E, Gatell J, Moran Y, et al.: High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis 1998;27:1510-1513.
12. Weinberg A, Wiznia AA, LaFleur BJ, Shah S, and Levin MJ: Varicella-zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis 2004;190:267-270.
13. Drew WL: Cytomegalovirus infection in patients with AIDS. J Infect Dis 1988;158:449-456.
14. Jacobson MA, and Mills J: Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): Clinical findings, diagnosis, and treatment. Ann Intern Med 1988;108:585-594.
15. Hayward AR, Zerbe GO, and Levin MJ: Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods 1994;170:27-36.
16. Levin MJ, Gershon AA, Weinberg A, et al.: Immunization of HIV-infected children with varicella vaccine. J Pediatr 2001;139: 305-310.
17. Weinberg A, Wohl DA, Barrett RJ, and van der Horst C: Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J Infect Dis 2001; 184:707-712.
18. Littell R, Milliken G, Stroup W, and Wolfinger R: SAS System for Mixed Models. Cary, North Carolina: SAS Institute, 1996.
19. Weinberg A, Wohl DA, MaWhinney S, et al.: Cytomegalovirus-specific IFN-γ production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapy. AIDS 2003;17:2445-2450.
20. Keane NM, Price P, Lee S, et al.: Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy. HIV Med 2004;5:407-414.
21. Jansen C, Piriou E, De Cuyper I, van Dort K, van Baarle D, and Miedema F: Long-term HAART in chronic HIV-1 infection: Evidence for reconstitution of antiviral immunity. In: 12th Conference on Retroviruses and Opportunistic Infections, Boston, MA: Foundation for Retrovirology and Human Health 2005, p. 224.
22. Weinberg A, Kendall MA, Tierney C, et al.: CMV-specific cell-mediated immunity confers protection against CMV viremia and end-organ disease in HIV-infected patients in the era of HAART. In: 12th Conference on Retroviruses and Opportunistic Infections, Boston, MA: Foundation for Retrovirology and Human Health; 2005, p. 225.
23. Weinberg A and Pott GB: Immunity to human immunodeficiency virus (HIV) in children with chronic HIV infection receiving highly active antiretroviral therapy. Clin Diagn Lab Immunol 2003; 10:821-825.
24. Weinberg A: The role of immune reconstitution in cytomegalovirus infection. Biodrugs 2002;16:89-95.
25. Springer KL and Weinberg A: Cytomegalovirus infection in the era of HAART: Fewer reactivations and more immunity. J Antimicrob Chemother 2004;54:582-586.
26. Posavad CM, Wald A, Kuntz S, et al.: Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy. J Infect Dis 2004;190:693-696.